Stock Analysis of Eloxx Pharmaceuticals Inc (ELOX) - Birds Eye View

1W   2W   1M   3M   1Y   2Y   5Y   
Overview
Code ELOX
Close 0.900
Change -0.061 / 6.36 %
Volume 11039.00
Vol Change -36693.00 / 76.87 %
IndustryBiotechnology
SectorHealthcare
AIO Strength Index
Technical StrengthBearish
Growth Index Very Low Growth Stock
Value Index Poor Value Stock
Profitability Index Very Low Profitability Stock
Stability Index Good Stability


Fundamental View of Eloxx Pharmaceuticals Inc
PE (TTM)

-11.49

Very Poor
Price / Book

-35.38

Very Poor
Price / Sales

0

Very Poor
Piotroski F Score

2.0

Poor
Market Cap

2829.05 K

Enterprise Value

2829.05 K

ROA (TTM)

-323.24

Very Poor
ROE (TTM)

0

Poor
Net Margin (TTM)

0

Poor
Revenue

%

0
Net Profit

43.21 %

-20482.00 K
Debt to Equity

0

Excellent
Altman Z Score

Indecisive
Quick Ratio

0

Poor
Cash Ratio

0

Poor


Highs/Lows of Eloxx Pharmaceuticals Inc
PeriodOld priceStock ReturnS&P 500 ReturnsHighLowHigh DateLow Date
One Week0.9611 6.36 % 0.513 % 0.90.8114-May-2414-May-24
Two Week0.9611 6.36 % 0.486 % 0.90.8114-May-2414-May-24
One Month0.9 0 % 4.80 % 1.150.8130-Apr-2414-May-24
Three Month0.82 9.76 % 3.56 % 1.150.770530-Apr-2421-Feb-24
Six Months3.82 76.44 % 15.54 % 1.250.770504-Jan-2421-Feb-24
One year3.56 74.72 % 26.26 % 10.90.770515-May-2321-Feb-24
Two year12.296 92.68 % 27.72 % 19.20.770525-Aug-2221-Feb-24
Five year448.0 99.80 % 91.77 % 19.20.770525-Aug-2221-Feb-24
Ten year2216.0 99.96 % 174.36 % 2600.00.770503-Jun-1421-Feb-24


Technical View of Eloxx Pharmaceuticals Inc
RSI

18.04

Mild Bullish
MACD

-1.12

Bearish
ADX

31.55

Bearish
Super Trend

2.16

Mild Bearish
Williams %R

-96.74

Mild Bullish
CCI

-100.72

Strong Bullish


EMA 5

1.13

Mild Bearish
EMA 15

2.36

Mild Bearish
EMA 50

4.03

Strong Bearish
EMA 100

4.74

Strong Bearish
SMA 100

5.11

Strong Bearish
SMA 200

5.05

Mild Bearish
SMA 5 / 20

0.966 / 3.26

Strong Bearish
SMA 15 / 50

2.75 / 4.36

Strong Bearish
SMA 50 / 200

4.36 / 5.05

Strong Bearish




Charts of Eloxx Pharmaceuticals Inc


Returns of Eloxx Pharmaceuticals Inc with Peers
Period / StockELOXMDVLSPRCVRAX
1 Week-6.36%-6.30%-17.70%31.11%
1 Mth0%-50.68%-33.57%87.30%
3 Mth9.76%-40.20%-75.65%22.60%
6mth-76.44%-84.89%-88.09%-49.25%
1 Year-74.72%-88.99%-94.66%-69.87%
2 Year-92.68%-97.23%-98.82%-
5 Years-99.80%-99.83%--
charts-
View All Together in Chart      Inline           Tile

Compare Fundamentals of Eloxx Pharmaceuticals Inc with Peers
Ratio / StockELOXMDVLSPRCVRAX
PE-11.49-0.462-0.200-0.367
P/B-35.380.7120.0500.822
ROA-323.24-99.91-18.28-169.55
ROE0-154.27-30.34-213.23
Debt To Equity00.2640.00680.0160
Revenue0
% 		43109.00 K
94.81 % 		2879.00 K
113.73 % 		8561.00
%
Net Income-20482.00 K
43.21 % 		-47616.00 K
8.68 % 		-5122.00 K
97.61 % 		-5457.49 K
219.37 %


Technicals of Eloxx Pharmaceuticals Inc with Peers
Technical / StockELOXMDVLSPRCVRAX-
ADX31.5516.7218.5726.56
CMF-0.2440.432-0.6090.292
MFI17.3490.892.3097.94
RSI18.0436.9420.1077.80
MACD Abv SignalFalseFalseTrueTrue
Price Above 50 MAFalseFalseFalseTrue-
Price Above 200 MAFalseFalseFalseFalse-


About : Eloxx Pharmaceuticals Inc

Address : 480 Arsenal Way, Watertown, MA, United States, 02472
Tel : 781 577 5300
URL : https://www.eloxxpharma.com
Code : ELOX, ISIN : US29014R1032, Exchange : PINK, Country : USA
Fiscal Year End : December
IPO date : 19_Jan_2018
Employee Count : 18

Eloxx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing ribosome modulation for the treatment of rare and ultra-rare premature stop codon diseases. Its lead investigational drug product candidate is ELX-02, which is in Phase 2 clinical trial for the treatment of cystic fibrosis and nephropathic cystinosis patients with diagnosed nonsense mutations. The company also develops various preclinical programs for the treatment of alport syndrome, recessive dystrophic epidermolysis bullosa, junctional epidermolysis bullosa, and familial adenomatous polyposis, as well as various earlier discovery stage programs in oncology. Eloxx Pharmaceuticals, Inc. was founded in 2013 and is headquartered in Watertown, Massachusetts.


Note : All Data Generated at the End of Trading Hours (EOD Data)